133 related articles for article (PubMed ID: 1328270)
1. Determination of enantiomeric concentrations of a 2,5-diaryltetrahydrofuran (L-668,750), a platelet-activating factor receptor antagonist, in rat plasma using a chiral alpha 1-acid glycoprotein high-performance liquid chromatographic column.
Alvaro RF; Rosegay A; Chiu SH
J Chromatogr; 1992 Jul; 578(2):327-32. PubMed ID: 1328270
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Alberts AW; Bugianesi RL; Chabala JC; Ponpipom MM
J Pharmacol Exp Ther; 1988 Aug; 246(2):534-41. PubMed ID: 2841449
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
Doebber TW; Wu MS; Biftu T
J Immunol; 1986 Jun; 136(12):4659-68. PubMed ID: 3011900
[TBL] [Abstract][Full Text] [Related]
4. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
Hwang SB; Lam MH; Hsu AH
Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468
[TBL] [Abstract][Full Text] [Related]
5. Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester.
Girotra NN; Biftu T; Ponpipom MM; Acton JJ; Alberts AW; Bach TN; Ball RG; Bugianesi RL; Parsons WH; Chabala JC
J Med Chem; 1992 Sep; 35(19):3474-82. PubMed ID: 1404229
[TBL] [Abstract][Full Text] [Related]
6. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
Hwang SB; Lam MH; Szalkowski DM; MacIntyre DE; Bach TJ; Luell S; Meuer R; Sahoo SP; Alberts AW; Chabala JC
J Lipid Mediat; 1993 Jun; 7(2):115-34. PubMed ID: 8400114
[TBL] [Abstract][Full Text] [Related]
7. Chemical and biochemical characterization of lignan analogs as novel PAF receptor antagonists.
Shen TY
Lipids; 1991 Dec; 26(12):1154-6. PubMed ID: 1668110
[TBL] [Abstract][Full Text] [Related]
8. High affinity receptor binding of platelet-activating factor in rat peritoneal polymorphonuclear leukocytes.
Hwang SB
Eur J Pharmacol; 1991 Apr; 196(2):169-75. PubMed ID: 1651872
[TBL] [Abstract][Full Text] [Related]
9. Rapid Enantiomeric Separation and Quantitation of Levetiracetam on α-Acid Glycoprotein (AGP) Chiral Stationary Phase by High-Performance Liquid Chromatography.
Heydari R; Shamsipur M
J AOAC Int; 2015; 98(6):1529-34. PubMed ID: 26651564
[TBL] [Abstract][Full Text] [Related]
10. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist.
Ponpipom MM; Hwang SB; Doebber TW; Acton JJ; Alberts AW; Biftu T; Brooker DR; Bugianesi RL; Chabala JC; Gamble NL
Biochem Biophys Res Commun; 1988 Feb; 150(3):1213-20. PubMed ID: 2829894
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models.
Nagaoka J; Harada K; Kimura A; Kobayashi S; Murakami M; Yoshimura T; Yamada K; Asano O; Katayama K; Yamatsu I
Arzneimittelforschung; 1991 Jul; 41(7):719-24. PubMed ID: 1663352
[TBL] [Abstract][Full Text] [Related]
12. Coupled-column chromatography on a Chiral-AGP phase for determination of amlodipine enantiomers in human plasma: an HPLC assay with electrochemical detection.
Josefsson M; Norlander B
J Pharm Biomed Anal; 1996 Nov; 15(2):267-77. PubMed ID: 8933429
[TBL] [Abstract][Full Text] [Related]
13. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
Tahraoui L; Floch A; Cavero I
J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
[TBL] [Abstract][Full Text] [Related]
14. Determination of ketorolac enantiomers in plasma using enantioselective liquid chromatography on an alpha 1-acid glycoprotein chiral stationary phase and ultraviolet detection.
Mills MH; Mather LE; Gu XS; Huang JL
J Chromatogr B Biomed Appl; 1994 Aug; 658(1):177-82. PubMed ID: 7952121
[TBL] [Abstract][Full Text] [Related]
15. High-performance liquid chromatographic method for the simultaneous determination of R-(-)- and S-(+)-hexobarbital in rat plasma.
Vermeulen AM; Rosseel MT; Belpaire FM
J Chromatogr; 1991 Jul; 567(2):472-9. PubMed ID: 1939480
[TBL] [Abstract][Full Text] [Related]
16. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
Tahraoui L; Floch A; Mondot S; Cavero I
Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
[TBL] [Abstract][Full Text] [Related]
17. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
Marquis O; Robaut C; Cavero I
J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
[TBL] [Abstract][Full Text] [Related]
18. (+/-)-trans-2-[3-methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N- hydroxyureidyl)methylphenyl]-5-(3,4, 5-trimethoxyphenyl)tetrahydrofuran (CMI-392), a potent dual 5-lipoxygenase inhibitor and platelet-activating factor receptor antagonist.
Cai X; Scannell RT; Yaeger D; Hussoin MS; Killian DB; Qian C; Eckman J; Hwang SB; Libertine-Garahan L; Yeh CG; Ip SH; Shen TY
J Med Chem; 1998 May; 41(11):1970-9. PubMed ID: 9599246
[TBL] [Abstract][Full Text] [Related]
19. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
[TBL] [Abstract][Full Text] [Related]
20. Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching.
Liu L; Cheng H; Zhao JJ; Rogers JD
J Pharm Biomed Anal; 1997 Feb; 15(5):631-8. PubMed ID: 9127275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
